CNBC Investing Club

We are beefing up our position even more in this best-of-breed drug stock

An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021.
Mike Segar | Reuters

(This article was sent first to members of the CNBC Investing Club with Jim Cramer. To get the real-time updates in your inbox, subscribe here.)

Shortly before the closing bell, we will be buying 50 shares of Eli Lilly (LLY) at roughly $255. Following the trade, the Charitable Trust will own 375 shares of Eli Lilly. This buy will increase Eli Lilly's weight in the portfolio from about 2.01% to 2.30%.